soulful sepulcher (Free subscription) | yesterday
Judge Weinstein : FDA: Eli Lilly: Accountability! Philip Dawdy:Furious Seasons Mental health news blog:October 05, 2007 "The Zyprexa Chronicles: Interview With Mother Of Zyprexa Victim The following is an interview with Ellen Liversidge, mother of Rob. He was a 39-year-old with bipolar disorder who died in 2002 after taking Zyprexa. Today is the fifth anniversary of his death." From the
Allergic Info (Free subscription) | 07/21/2008
Eli Lilly and Company (NYSE: LLY) be announcing starting grades from the Raloxifene Use contained by support of The Heart try-out (RUTH), a large-scale placebo-controlled revise that investigate whether 60 mg day by day dose of raloxifene HCl would drain the venture of coronary trial (e.g., heart attack) and the risk of forward breast cancer in postmenopausal women near clot heart weakness or at big...
PR News Wire (Free subscription) | 07/16/2008
New contract service offering rapid development of high performance HEK293 (human) production cell lines enabled by Selexis Genetic Elements(TM) and Selexis SURE(TM) Cell Line Development program GENEVA, July 16 /PRNewswire/ -- Selexis SA, a Swiss-based biotechnology Company offering DNA based technologies and supportive services to enable significantly improved drug discovery, development, and...
PR News Wire (Free subscription) | 07/16/2008
Majority of men rank discomfort as #1 reason to avoid discussing ED, a potential precursor to heart disease INDIANAPOLIS, July 16 /PRNewswire-FirstCall/ -- A new survey reveals that while 82 percent of men with erectile dysfunction (ED) surveyed recognize it as an indicator of other health conditions, such as heart disease and diabetes, nearly 40 percent have never discussed the condition with their...
Hispanic Business Magazine (Free subscription) | 07/13/2008
SAN DIEGO, July 13 /PRNewswire-FirstCall/ -- Eli Lilly and Company has partnered with the National Council of La Raza (NCLR) to unveil a small tool aimed at battling a big problem -- chronic disease....
IPKat—IP news and fun for everyone (Free subscription) | 07/06/2008
The IPKat can now reveal that leave to appeal to the House of Lords has been refused in Eli Lilly and Company and others v 8PM Chemist Limited . This was the case in which 8PM enabled US patients to obtain cheap prescription drugs from Turkey via a rather circuitous route which passed through the UK, where Eli Lilly had some trade marks which, it considered, this trade route infringed. At first instance...
PR News Wire (Free subscription) | 07/10/2008
Independent audit will verify Company's compliance INDIANAPOLIS, July 10 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: ) today announced its support of the Pharmaceutical Research and Manufacturers of America (PhRMA) revised Code on Interactions with Healthcare Professionals (Code). As a part of its support, Lilly will commit to act in accordance with, or exceed, the new Code in its interactions...
PR News Wire (Free subscription) | 07/08/2008
Deal Expands Lilly's Structure-Based Drug Discovery Capabilities INDIANAPOLIS, and SAN DIEGO, July 8 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: ) and SGX Pharmaceuticals, Inc. (Nasdaq: ) today announced that the companies have signed a definitive merger agreement providing for the acquisition of SGX in an all-cash transaction. SGX, based in San Diego, California, is a biotechnology Company...
PR News Wire (Free subscription) | 07/07/2008
Premier Organization for African Americans in IT and Leading Diversity Job Board Recognize Best Companies for Blacks in Technology LARGO, Md. and PARSIPPANY, N.J., July 7 /PRNewswire/ -- The National BDPA, Black Data Processing Associates ), and WorkplaceDiversity.com ), the source for diversity talent, announced Allstate Insurance, Eli Lilly and Company, Health Care Service Corporation, HSBC North...
Allergic Info (Free subscription) | 06/28/2008
About Lilly ICOS LLC Lilly ICOS LLC, a cohesive scheme going on for ICOS Corporation and Eli Lilly and Company, mechanized Cialis all for the nursing of erectile dysfunction . ICOS Corporation, a biotechnology ensemble headquartered within Bothell, Washington, be staunch to bring radical therapeutics to patients. ICOS is utilizable to drag your socks wide awake treatment for bookish unmet medical provisos...
Forensics Talk (Free subscription) | 07/02/2008
Medical News Today Main Category: Diabetes Also Included In: Aid / Disasters Article Date: 24 Jun 2008 - 1:00 PDT Natural disasters in 2008 have proved that hurricane season isn't the only time a person should be prepared for the worst. That is why the American Association of Clinical Endocrinologists...
PR News Wire (Free subscription) | 06/25/2008
INDIANAPOLIS, June 25 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: ) will announce its financial results for the second quarter of 2008 on Thursday, July 24, 2008. Lilly will also conduct a conference call on that day with the investment community and media to further detail the Company's financial performance. The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT. Investors,...
PR News Wire (Free subscription) | 06/24/2008
Companies confirm the start of TRILOGY ACS clinical trial to study Prasugrel against Clopidogrel in medically managed ACS patients TOKYO and INDIANAPOLIS, June 23 /PRNewswire-FirstCall/ -- Daiichi Sankyo Company, Limited, (TSE:4568) and Eli Lilly and Company (NYSE: ) said that the U.S. Food and Drug Administration (FDA) has extended the review period for the prasugrel new drug application (NDA)...
ChinaTechNews.com (Free subscription) | 06/22/2008
Statistics from China's Ministry of Commerce show that 12 companies, including Nokia, Google China, and Texas Instruments, have not fulfilled their promise of making donations to China's earthquake areas, but most of the companies say that they have been wronged as Ministry of Commerce's statistics are incomplete. According to the data released by Ministry of Commerce's [...]
China Law Blog (Free subscription) | 06/18/2008
Managing Intellectual Property Magazine will, on June 19 at noon Eastern time (US) be putting on a Free Webinar on Anti-Counterfeiting Strategies, entitled “Global Anti-Counterfeiting Strategies: Tackling Trans-shipment Issues Using Customs and Other Enforcement Techniques.” The scheduled speakers are: -- James Nurton, Editor of Managing IP -- Paul Rawlinson and Andy Leck of Baker & McKenzie. -- Toe...
